𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Studies of the Effects of Central Administration of β-Amyloid Peptide (25–35): Pathomorphological Changes in the Hippocampus and Impairment of Spatial Memory

✍ Scribed by M. Yu. Stepanichev; I. M. Zdobnova; I. I. Zarubenko; N. A. Lazareva; N. V. Gulyaeva

Publisher
Springer US
Year
2006
Tongue
English
Weight
125 KB
Volume
36
Category
Article
ISSN
0097-0549

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of tumor necrosis factor-alpha c
Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25–35)
✍ Mikhail Yu. Stepanichev; Irina M. Zdobnova; Alexander A. Yakovlev; Mikhail V. On 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

## Abstract Male Wistar rats received unilateral intrahippocampal injections of 3 nmol (3.18 μg) aggregated Aβ(25–35), intracerebroventricular bilateral injections of 0.5 μg human recombinant TNFα or both (Aβ(25–35) + TNFα‐treated animals). Seven days after the surgery brain sections were stained w

Chronic but not acute intracerebroventri
Chronic but not acute intracerebroventricular administration of amyloid β-peptide(25–35) decreases somatostatin content, adenylate cyclase activity, somatostatin-induced inhibition of adenylate cyclase activity, and adenylate cyclase I levels in the rat hippocampus
✍ E. Burgos-Ramos; A. Hervás-Aguilar; L. Puebla-Jiménez; M.C. Boyano-Adánez; E. Ar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract Although alterations in adenylate cyclase (AC) activity and somatostatin (SRIF) receptor density have been reported in Alzheimer's disease, the effects of amyloid β‐peptide (Aβ) on these parameters in the hippocampus are unknown. Our aim was to investigate whether the peptide fragment A